<p>The present invention is directed to an animal model for predicting the course of orthopox virus infections or for evaluating the efficacy of anti-viral therapeutics or anti-orthopox virus vaccines. The present invention is further directed to a method of evaluating the efficacy of an anti-viral therapeutic or an anti-orthopox virus vaccine and to a specific Callithrixpox virus strain for use in this method. Furthermore, the present invention pertains to a pharmaceutical composition containing such an anti-viral therapeutic or an anti-orthopox virus vaccine.</p>
申请公布号
EP1826264(A1)
申请公布日期
2007.08.29
申请号
EP20060003847
申请日期
2006.02.24
申请人
DEUTSCHES PRIMATENZENTRUM GMBH
发明人
KAUP, FRANZ-JOSEF, PROF. DR.;MAETZ-RENSING, KERSTIN, DR.;STAHL-HENNIG, CHRISTIANE, DR.;PAULI, GEORG, PROF.;ELLERBROK, HEINZ, DR.